(MENAFN- Investor Brand Network) Shares of Keysight Technologies Inc. (NYSE:KEYS) traded today at $198.59, eclipsing its 52-week high. So far today approximately 535,000 shares have been exchanged, as compared to an average 30-day volume of 754,000 shares.
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
Keysight Technologies Inc. (NYSE:KEYS) defies analysts with a current price ($194.55) 26.2% above its average consensus price target of $143.65.
Over the past year, Keysight Technologies Inc. has traded in a range of $115.71 to $198.59 and is now at $194.55, 68% above that low.
Receive IBN Spotlights –“Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights , please visit
About IBN (InvestorBrandNetwork)
IBN consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years . Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and Code Editorial Syndication to 5,000+ broadcast outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series . With a proven track record serving 500+ client partners , IBN is the key to a more effective market communication campaign and the NEW normal.
For more information on IBN, please visit
Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.